Recent insider trading activity from Lacey John III, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 2, 2024 | PROVECTUS BIOPHARMACEUTICALS, INC. | $PVCT | Lacey John III | Director | A | Stock Options (Right to Buy) | 775082 | $0.00 | 775,082.0000 | 0 | 9999.99% | 0.00% |
| Sept. 30, 2024 | PROVECTUS BIOPHARMACEUTICALS, INC. | $PVCT | Lacey John III | Director | A | Series D-1 Convertible Preferred Stock | 179592 | $0.00 | 179,592.0000 | 0 | 9999.99% | 0.00% |